PRESS AND MEDIA

MEDIA SUPPORT

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Principal manager
Media relations and corporate communication

Email: Kathy Robertson

Tel: (351) 211 21 02 00/32

Mobile. (351) 935 994 027

News

Displaying 1 - 2 of 2

News

New multi-city syringe study uncovers latest patterns of injecting drug use

17.02.2021

The latest patterns of injecting drug use in a selection of European cities are explored today in a new study from the EMCDDA. The report presents the results of an innovative project...

News

New EMCDDA report explores combined mental health and substance use disorders

27.11.2015

The co-existence of mental illness and psychoactive drug or other substance use problems — otherwise known as ‘comorbidity’ or ‘dual diagnosis’ — is an issue which has been on the radar of...

Quick links

Statistical Bulletin 2022

Publications quick links

PRESS AND MEDIA

MEDIA SUPPORT

News

New multi-city syringe study uncovers latest patterns of injecting drug use

New EMCDDA report explores combined mental health and substance use disorders

About the EMCDDA

Main navigation

Statistical Bulletin 2022

Best practice

Publications

Publications quick links

Events

PRESS AND MEDIA

NEWSLETTER

MEDIA SUPPORT

News

New multi-city syringe study uncovers latest patterns of injecting drug use

New EMCDDA report explores combined mental health and substance use disorders